Loading clinical trials...
Loading clinical trials...
The purpose of this study is to characterize the pharmacokinetic (PK) and pharmacodynamic (PD) profiles to determine the safety and tolerability of single and multiple doses of pantoprazole in infants...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Collaborators
NCT02616302 · Gastroesophageal Reflux Disease (GERD)
NCT05132816 · Gastroesophageal Reflux, Esophageal Motility Disorders, and more
NCT06926374 · Colorectal Carcinoma, Rectal Prolapse, and more
NCT00590239 · Barrett's Esophagus, Neoplasms, and more
NCT04506593 · Eosinophilic Esophagitis, Gastroesophageal Reflux Disease (GERD), and more
Little Rock, Arkansas
Loma Linda, California
San Diego, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions